Author Topic: Medicare Part D letting patients down when it comes to generic versions of MS drugs  (Read 26 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest

MS drugs are among the drugs under discussion in this article, which points out that the increasing availability of generic forms of some pricey brand-name drugs actually may mean that Medicare beneficiaries will be paying more out of pocket for the generic form of a drug than for the brand-name variety. This article, "Broken Promises--How Medicare Part D Has Failed to Deliver Savings to Older Adults," is in the New England Journal of Medicine (December 5, 2020):


https://www.nejm.org/doi/full/10.1056/NEJMp2027580?query=WB
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
96 Views
Last post July 07, 2016, 01:40:33 pm
by agate
0 Replies
37 Views
Last post November 17, 2019, 08:49:02 pm
by agate
0 Replies
39 Views
Last post October 11, 2020, 02:50:55 pm
by agate
0 Replies
27 Views
Last post June 29, 2021, 08:57:58 pm
by agate
0 Replies
9 Views
Last post May 14, 2022, 06:53:43 am
by agate